[VALUE OF AN INTRADERMAL TREATMENT DESIGNED TO INCREASE THE TOLERANCE OF THE ORGANISM TO THE MYCOBACTERIAL COMPONENT OF A NUMBER OF CHRONIC DERMATOSES. (A 5-YEAR EXPERIMENT ON APPROXIMATELY 2,500 PATIENTS].
D000917:Antibody Formation; D035843:Biomedical Research; D003880:Dermatology; D006801:Humans; D006967:Hypersensitivity; D012871:Skin Diseases; D012882:Skin Tests; D014374:Tuberculin Test
ANTIBODY FORMATION; CLINICAL RESEARCH; DERMATOLOGY; HYPERSENSITIVITY; SKIN TESTS; TUBERCULIN TEST
INT'ER ET D'UN TRAITEMENT INTRADERMIQUE DESTIN'E 'A SUSCITER LA TOL'ERANCE DE L'ORGANISME 'A LA COMPOSANTE MYCOBACT'ERIENNE DE NOMBRE DE DERMATOSES CHRONIQUES. (UNE EXP'ERIENCE DE CINQ ANS PORTANT SUR 2.500 MALADES ENVIRON)